Medeical Therapy For Pulmonary Arterial Hypertention / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
;
: 142-150, 2006.
Article
in Korean
| WPRIM
| ID: wpr-69165
ABSTRACT
Pulmonary arterial hypertension (PAH) is often difficult to diagnose and challenging to treat. Untreated, it is characterized by a progressive increase in pulmonary vascular resistance leading to right ventricular failure and death. The past decade has seen remarkable improvements in therapy, driven largely by the conduct of randomized controlled trials. Still, the selection of most appropriate therapy is complex, and requires familiarity with the disease process, evidence from treatment trials, complicated drug delivery systems, dosing regimens, side effects, and complications. We tried to provide evidence?based treatment recommendations for physicians involved in the care of these complex patients. Due to the complexity of the diagnostic evaluation required, and the treatment options available, it is strongly recommended that consideration be given to referral of patients with PAH to a specialized center.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Referral and Consultation
/
Vascular Resistance
/
Drug Delivery Systems
/
Recognition, Psychology
/
Hypertension
/
Nitric Oxide
Type of study:
Controlled clinical trial
/
Practice guideline
Limits:
Humans
Language:
Korean
Journal:
Tuberculosis and Respiratory Diseases
Year:
2006
Type:
Article
Similar
MEDLINE
...
LILACS
LIS